Kansas City Research Institute

Kansas City Research Institute Phase I-IV Clinical Research Trials Kansas City Research Institute is lead by board-certified Gastroenteroloigist and Hepatologist Dr. Bradley Freilich.

Dr. Freilich has over 25 years of clinical research experience in phases I-IV trials and has conducted over 300 clinical research trial for patients in the Kansas City metro and surrounding areas. KCRI has been instrumental in the process it takes to bring new treatments to the public. Without physicians like Dr. Bradley Freilich and places like KCRI, many treatments may never receive FDA approval or be available to you. To learn more, please check out our website www.kcresearchinstitute.com

03/03/2026

📍 We’ve Moved!
Kansas City Research Institute (KCRI) has a new home! 🎉
We’re still part of the Research Medical Center – Brookside campus, just at a new location.

🏢 New Address
6667 Holmes Road, Suite 129
Kansas City, MO 64131

đźš— Getting Here Is Easy
✔️ Park in Lot B off Holmes Road (north of Lot C)
✔️ Walk toward the building and head around to the back
✔️ Look for the red and brown striped awning — that’s us!

Please use this address for all future visits. We can’t wait to welcome you to our new space and continue supporting your care and research journey. 💙

👉 Save this post for your next visit
👉 Share with anyone who may be coming with you

Happy New Year!
12/31/2025

Happy New Year!

12/09/2025
Happy Thanksgiving!
11/26/2025

Happy Thanksgiving!

Dr. Freilich, the leader of our research team, has participated in over 200 clinical trials. Our research institute is o...
01/18/2023

Dr. Freilich, the leader of our research team, has participated in over 200 clinical trials. Our research institute is outfitted with the highest-grade tools and equipment, making us capable of leading research endeavors. https://kcresearchinstitute.com/kcri-capabilities/

Cirrhosis is a development of scarring on the liver as a result of extended liver damage. While the condition is irrever...
01/09/2023

Cirrhosis is a development of scarring on the liver as a result of extended liver damage. While the condition is irreversible, KCRI offers a variety of treatment options from non-invasive liver scans to clinical trials. Read our latest blog to learn more âžť https://kcresearchinstitute.com/cirrhosis-treatment/

The providers at KCRI recommend FibroScan® tests be repeated every 6-12 months to monitor the progression of liver disea...
12/20/2022

The providers at KCRI recommend FibroScan® tests be repeated every 6-12 months to monitor the progression of liver disease. Should you start a treatment or make lifestyle changes, we can provide you with a follow-up examination to measure the impact the treatment/lifestyle change had on your liver!

The sooner you know the state of your liver, the sooner you can act to prevent irreversible liver damage. Call us at 816-759-5274 to schedule your FibroScan appointment!

FibroScan is a non-invasive alternative to traditional liver biopsy. The results can be used to measure liver health, tr...
12/19/2022

FibroScan is a non-invasive alternative to traditional liver biopsy. The results can be used to measure liver health, track disease progession, and recommend patients to treatment options. Get started with KCRI with a FibroScan now. https://kcresearchinstitute.com/request-a-call/

Address

6667 Holmes Road, #129
Kansas City, MO
64131

Alerts

Be the first to know and let us send you an email when Kansas City Research Institute posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Category